Shock séptico en la Unidad de Cuidados Intensivos. Terapéutica avanzada, inmunoparálisis y genómica. Estado del arte

Translated title of the contribution: Septic shock in ICU: Advanced therapeutics, immunoparalysis and genomics. State of the art

Arriagada S. Daniela, Donoso F. Alejandro, Cruces R. Pablo, Díaz R. Franco

Research output: Contribution to journalArticlepeer-review

Abstract

New and important concepts have emerged for the advanced management of the child with septic shock in the recent decades. Attending physicians in the Pediatric intensive care unit must be fully aware of them to improve patient care in the critical care unit. It should be considered the use of immune therapy only in selected groups of patients. Continuous renal replacement therapies are well tolerated and their early use prevents deleterious fluid overload. Removal of inflammatory mediators by using high volume hemofiltration may play a role in hyperdynamic septic patients. The use of plasmapheresis is recommended in patients with thrombocytopenia-associated multiple organ failure. Extracorporeal support use should be considered in those with refractory septic shock despite goals directed therapy. The immunoparalysis has been associated with nosocomial infections and late mortality. The information from genetic markers may allow early intervention and preventive genomicsbased medicine.

Translated title of the contributionSeptic shock in ICU: Advanced therapeutics, immunoparalysis and genomics. State of the art
Original languageSpanish
Pages (from-to)358-365
Number of pages8
JournalArchivos Argentinos de Pediatria
Volume112
Issue number4
DOIs
Publication statusPublished - 1 Aug 2014

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Septic shock in ICU: Advanced therapeutics, immunoparalysis and genomics. State of the art'. Together they form a unique fingerprint.

Cite this